{"id":"https://openalex.org/W65600113","doi":null,"title":"Pharmacokinetics of intravenously administered liposomal all-trans-retinoic acid (ATRA) and orally administered ATRA in healthy volunteers.","display_name":"Pharmacokinetics of intravenously administered liposomal all-trans-retinoic acid (ATRA) and orally administered ATRA in healthy volunteers.","publication_year":2003,"publication_date":"2003-05-01","ids":{"openalex":"https://openalex.org/W65600113","mag":"65600113","pmid":"https://pubmed.ncbi.nlm.nih.gov/12935441"},"language":"en","primary_location":{"id":"pmid:12935441","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12935441","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques","raw_type":"Clinical Trial"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5040193650","display_name":"B\u00fclent \u00d6zpolat","orcid":"https://orcid.org/0000-0001-8602-7463","observed_orcids":["https://orcid.org/0000-0001-8602-7463"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Bulent Ozpolat","raw_affiliation_strings":["Department of Bioimmunotherapy, Section of Immunobiology and Drug Carriers, The University of Texas M. D. Anderson Cancer Center, Houston 77030, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Bioimmunotherapy, Section of Immunobiology and Drug Carriers, The University of Texas M. D. Anderson Cancer Center, Houston 77030, USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023542865","display_name":"Gabriel Lopez\u2010Berestein","orcid":"https://orcid.org/0000-0002-0366-0720","observed_orcids":["https://orcid.org/0000-0002-0366-0720"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gabriel Lopez-Berestein","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066484657","display_name":"Peter C. Adamson","orcid":"https://orcid.org/0000-0002-9487-757X","observed_orcids":["https://orcid.org/0000-0002-9487-757X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Peter Adamson","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036148623","display_name":"ChauHwei J Fu","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"ChauHwei J Fu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5070807244","display_name":"A. H. Williams","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anthony H Williams","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.5085,"has_fulltext":false,"cited_by_count":80,"citation_normalized_percentile":{"value":0.79888798,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"6","issue":"2","first_page":"292","last_page":"301"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11559","display_name":"Retinoids in leukemia and cellular processes","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11559","display_name":"Retinoids in leukemia and cellular processes","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/all-trans-retinoic-acid","display_name":"all-trans retinoic acid","score":0.9079999923706055},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.8569999933242798},{"id":"https://openalex.org/keywords/intravenous-administration","display_name":"intravenous administration","score":0.9580000042915344},{"id":"https://openalex.org/keywords/oral-administration","display_name":"oral administration","score":0.996999979019165},{"id":"https://openalex.org/keywords/repeated-dosing","display_name":"repeated dosing","score":0.6359999775886536},{"id":"https://openalex.org/keywords/plasma-concentration","display_name":"plasma concentration","score":0.550000011920929},{"id":"https://openalex.org/keywords/liver-function-tests","display_name":"liver function tests","score":0.8790000081062317},{"id":"https://openalex.org/keywords/acute-promyelocytic-leukemia","display_name":"acute promyelocytic leukemia","score":0.9679999947547913},{"id":"https://openalex.org/keywords/retinoids","display_name":"retinoids","score":0.7360000014305115}],"concepts":[{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.8764184713363647},{"id":"https://openalex.org/C2777056448","wikidata":"https://www.wikidata.org/wiki/Q285166","display_name":"Oral administration","level":2,"score":0.7005596160888672},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6769117712974548},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6600157618522644},{"id":"https://openalex.org/C2779963572","wikidata":"https://www.wikidata.org/wiki/Q29417","display_name":"Tretinoin","level":4,"score":0.573632001876831},{"id":"https://openalex.org/C76318530","wikidata":"https://www.wikidata.org/wiki/Q16833590","display_name":"Area under the curve","level":2,"score":0.5660337209701538},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.4869471788406372},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.46818387508392334},{"id":"https://openalex.org/C2781121885","wikidata":"https://www.wikidata.org/wiki/Q425517","display_name":"Retinoic acid","level":3,"score":0.4667986035346985},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.31721389293670654},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.2320442497730255},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.07444390654563904},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D004337","descriptor_name":"Drug Carriers","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008081","descriptor_name":"Liposomes","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011446","descriptor_name":"Prospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014212","descriptor_name":"Tretinoin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D014212","descriptor_name":"Tretinoin","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true}],"locations_count":2,"locations":[{"id":"pmid:12935441","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12935441","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques","raw_type":"Clinical Trial"},{"id":"mag:65600113","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12935441","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":45,"referenced_works":["https://openalex.org/W72696115","https://openalex.org/W79968274","https://openalex.org/W115875242","https://openalex.org/W1505374702","https://openalex.org/W1750460473","https://openalex.org/W1752169014","https://openalex.org/W1929961290","https://openalex.org/W1971391507","https://openalex.org/W1979794772","https://openalex.org/W1987820038","https://openalex.org/W1997473510","https://openalex.org/W2000502515","https://openalex.org/W2001238939","https://openalex.org/W2008296541","https://openalex.org/W2018650295","https://openalex.org/W2029654186","https://openalex.org/W2029928472","https://openalex.org/W2034987983","https://openalex.org/W2043887757","https://openalex.org/W2052539181","https://openalex.org/W2053287655","https://openalex.org/W2057560190","https://openalex.org/W2076108719","https://openalex.org/W2082558602","https://openalex.org/W2086225584","https://openalex.org/W2088940256","https://openalex.org/W2109568316","https://openalex.org/W2134001087","https://openalex.org/W2145836072","https://openalex.org/W2151347057","https://openalex.org/W2160970915","https://openalex.org/W2165339228","https://openalex.org/W2167386140","https://openalex.org/W2170947784","https://openalex.org/W2177441413","https://openalex.org/W2185703542","https://openalex.org/W2270944920","https://openalex.org/W2314212138","https://openalex.org/W2318214416","https://openalex.org/W2343463909","https://openalex.org/W2396977323","https://openalex.org/W2407345634","https://openalex.org/W2413626681","https://openalex.org/W2417867068","https://openalex.org/W2421553221"],"related_works":["https://openalex.org/W2605381562","https://openalex.org/W2413626681","https://openalex.org/W2086225584","https://openalex.org/W2069446399","https://openalex.org/W51256568","https://openalex.org/W2185703542","https://openalex.org/W1929961290","https://openalex.org/W130028085","https://openalex.org/W2021614772","https://openalex.org/W2142827362"],"abstract_inverted_index":{"PURPOSE:":[0],"To":[1],"determine":[2],"single-and":[3],"multiple-dose":[4],"pharmacokinetics":[5],"of":[6,98,107,126,178,192,208,222,261],"liposomal-all-":[7],"trans":[8],"-retinoic":[9],"acid":[10],"(Atragen)":[11],"following":[12],"intravenous":[13],"and":[14,69,81,92,124,128,151,163,198,226,253],"oral":[15,53,112,158,212,232,251],"ATRA":[16,54,99,113,159,213,229,233,252],"(Vesanoid)":[17],"administration":[18,221],"in":[19,32,75,116,120,190,206,234,258],"healthy":[20,235],"volunteers.":[21],"METHODS:":[22],"This":[23],"was":[24,149,188],"a":[25,117,242],"randomized,":[26],"prospective,":[27],"open-label,":[28],"parallel":[29],"pharmacokinetic":[30,244],"study":[31,80],"which":[33,187],"29":[34],"subjects":[35,73,194,210,236],"were":[36,63,82,181,204],"given":[37],"90":[38],"mg/m":[39,51],"(2)":[40,52],"i.v.":[41,220],"liposomal":[42],"(L)-ATRA":[43],"(16":[44],"subjects)":[45,56],"every":[46],"other":[47,266],"day":[48,132,139],"or":[49,265],"45":[50],"(13":[55],"daily":[57],"over":[58,250],"15":[59,105],"days.":[60],"Pharmacokinetic":[61],"parameters":[62],"assessed":[64],"on":[65,131,160],"days":[66,106,161],"1,":[67],"9,":[68,164],"15.":[70],"RESULTS:":[71],"Twenty-two":[72],"(11":[74],"each":[76,179],"group)":[77],"completed":[78],"the":[79,86,104,111,121,145,167,175,193,209,259],"evaluated.":[83],"Area":[84],"under":[85],"plasma":[87,94,170,228],"concentration-time":[88],"curve":[89],"[AUC(0,":[90],"infinity)]":[91],"maximum":[93],"concentration":[95],"(C(max)":[96],")":[97],"did":[100],"not":[101],"decrease":[102,119],"during":[103],"L-ATRA":[108,155,173,196,223,240],"treatment.":[109],"However,":[110],"regimen":[114],"resulted":[115],"significant":[118],"AUC(0,":[122,147],"infinity)":[123,148],"C(max)":[125],"45.3%":[127],"31.8%,":[129],"respectively,":[130],"9":[133],"as":[134],"compared":[135],"with":[136,241],"that":[137,203,219],"to":[138],"1":[140,162],"(p<":[141],"0.05).":[142],"In":[143],"addition,":[144],"mean":[146],"13-":[150],"22-fold":[152],"greater":[153],"for":[154,157,184],"than":[156,231],"respectively.":[165],"Despite":[166],"significantly":[168],"higher":[169,225],"concentrations":[171,230],"after":[172,195,211,237],"treatment,":[174],"side":[176],"effects":[177],"formulation":[180],"similar,":[182],"except":[183],"dermal":[185],"exfoliation,":[186],"seen":[189,205],"31%":[191],"dosing,":[197],"abnormal":[199],"liver":[200],"function":[201],"tests":[202],"23%":[207],"administration.":[214,239],"CONCLUSIONS:":[215],"These":[216],"findings":[217],"suggest":[218],"maintains":[224],"stable":[227],"repetitive":[238],"favorable":[243],"profile":[245],"may":[246,254],"have":[247],"potential":[248],"advantages":[249],"be":[255],"more":[256],"efficacious":[257],"treatment":[260],"acute":[262],"promyelocytic":[263],"leukemia":[264],"retinoid-responsive":[267],"cancers.":[268]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":5},{"year":2018,"cited_by_count":7},{"year":2017,"cited_by_count":5},{"year":2015,"cited_by_count":7},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":7},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}